Adrenoleukodystrophy: New approaches to a neurodegenerative disease

Hugo W. Moser, Gerald V. Raymond, Prachi Dubey

Research output: Contribution to journalArticle

108 Scopus citations

Abstract

X-linked adrenoleukodystrophy (X-ALD), which was first described in 1923, was viewed until 1976 as a rare and inexorably fatal neurodegenerative disorder that affected boys. The genetic defect and biochemical abnormalities have now been defined. Ongoing research has resulted in new findings: (1) there is a wide range of phenotypic expression. At least half of patients with X-ALD are adults with somewhat milder manifestations, and women who are carriers may become symptomatic. X-ALD is often misdiagnosed as attention-deficit/hyperactivity disorder in boys and as multiple sclerosis in men and women, and is not an uncommon cause of Addison disease; (2) the incidence of X-ALD, estimated to be 1:17 000 in all ethnic groups, approximates that of phenylketonuria; (3) noninvasive and presymptomatic diagnosis and prenatal diagnosis are available; family screening and genetic counseling are key to disease prevention; and (4) new therapies, applied early, show promise. Neonatal screening is likely to become available, and a wider awareness of X-ALD and its various modes of presentation permit new proactive approaches to this distressing disorder.

Original languageEnglish (US)
Pages (from-to)3131-3134
Number of pages4
JournalJournal of the American Medical Association
Volume294
Issue number24
DOIs
StatePublished - Dec 28 2005

Fingerprint Dive into the research topics of 'Adrenoleukodystrophy: New approaches to a neurodegenerative disease'. Together they form a unique fingerprint.

Cite this